#USA #Cancer Research #Tampa #Tampa General Hospital #USF Health

Tampa General Hospital to Host 'Microbes, Genes & Cancer' Symposium

In a monumental gathering for the field of oncological research, Tampa General Hospital's Cancer Institute, in collaboration with the USF Health Morsani College of Medicine, is set to host the 'Microbes, Genes & Cancer' Symposium on March 2-3, 2026. This symposium will attract renowned cancer researchers, clinicians, and translational scientists from various disciplines, showcasing the interplay between microbes, genetics, and cancer.

This event coincides with the fifth anniversary of the TGH Cancer Institute, marking a celebration of advancements in cancer research and treatment over the years. The symposium will feature prominent figures in cancer research who specialize in cancer viruses, immunology, and translational oncology. Attendees will have the opportunity to learn about the latest innovations in the diagnosis and treatment of malignancies linked to viral and bacterial activities, as well as recent breakthroughs in the fields of microbiome research and immunotherapy.

The symposium is particularly timely, as it addresses emerging evidence connecting the microbial environments within the body, immune system responses, and cancer risks across multiple tumor types. Experts will delve into pressing topics such as viral and bacterial carcinogenesis, the interactions between tumors and the microbiome, and emerging therapeutic targets and strategies. A special focus will also be on the cancer risks associated with long-term survivors of HIV, recognizing the complexities of treatment in this group.

One key session on March 3 will honor Dr. Robert C. Gallo and his colleagues, commemorating the 50th anniversary of their groundbreaking discovery of interleukin-2 (IL-2), a cytokine that has paved the way for modern immunotherapy. The session, titled '50 Years of Interleukin-2 Discovery,' aims to highlight Dr. Gallo's lasting impact in the field of cancer treatment and will feature a distinguished group of speakers including members of the National Academy of Sciences.

Experts scheduled to speak include:

• - Dr. Robert C. Gallo (USF Health Institute for Translational Virology & Innovation)
• - Dr. Steve Rosenberg (National Cancer Institute)
• - Dr. Carl June (University of Pennsylvania)
• - Dr. Drew M. Pardoll (Johns Hopkins University)
• - Dr. Rafi Ahmed (Emory University)
• - Dr. Warren Leonard (National Cancer Institute)

The 'Microbes, Genes & Cancer' Symposium will precede the annual Global Virus Network Scientific Meeting, scheduled for March 4-6, thus framing an entire week dedicated to scientific innovation and collaboration in the realm of virology and oncology. This event is designed not only for seasoned researchers but also for trainees and early-career scientists, encouraging cross-disciplinary dialogue that could lead to future collaborations.

The venue for the symposium, the USF Health Morsani College of Medicine, is located in downtown Tampa, easily accessible for attendees from both national and international backgrounds. Registration is currently open, making it an exciting time for those interested in exploring cutting-edge research and establishing connections within the cancer research community.

Who Should Attend?

This event is a must for:

• - Cancer researchers and clinician-scientists
• - Immunologists and microbiologists
• - Infectious disease specialists
• - Translational and computational researchers
• - Oncology fellows, residents, and trainees
• - Leaders from industry and academia focusing on cancer biology and immunotherapy

About Tampa General Hospital Cancer Institute

The TGH Cancer Institute is a prominent institution within Florida’s medical landscape, recognized for its academic partnerships and high-quality care. Rated among the top 10% of hospitals by U.S. News & World Report, TGH Cancer Institute is dedicated to research, treatment, and community outreach. The institute is also a member of the Association of American Cancer Institutes, reinforcing its position as a leader in cancer research and education.

With an ongoing commitment to advancing both patient care and scientific research, Tampa General Hospital continues to pave the way for innovative treatments and collaborations in the fight against cancer. To learn more, visit TGH Cancer Institute.